Chemical Structure (Tibsovo 01)
Tibsovo Tablet, Film Coated
Product Images NDC 72694-617
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tibsovo (NDC 72694-617). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Servier Pharmaceutical Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
250 mg Tablet 60-count Bottle Label (Tibsovo 02)
The text describes a graph that shows the overall survival probability of patients with AG120+zaitidine and Placsborazasiticine. The X-axis represents the number of patients at risk, and the Y-axis represents the overall survival in months. The graph shows that AG120+zaitidine has a higher survival probability than Placsborazasiticine.*
Chemical Structure (Tibsovo 03)
250 mg Tablet 60-count Carton Label (product Of Usa) (Tibsovo 04)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
